2 天前 - … Recent investigations have underscored the pivotal role of ferroptosis in the
pathogenesis of rheumatoid arthritis, ulcerative colitis, systemic lupus erythematosus, and asthma. …

4 天前 - Autoimmune rheumatic diseases comprise a group of immune-related disorders
characterized by non-organ-specific inflammation. These diseases include systemic lupus …

10 天前 - … The use of CD19-targeted therapy may represent an advancement for patients
with refractory autoantibody-mediated autoimmune diseases, particularly as the treatment only …

11 天前 - Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with
protean clinical manifestations and an erratic clinical course. Among its various clinical …

12 天前 - … shown to be increased in patients with systemic lupus erythematosus (SLE). While
DN2 … thesis advance our understanding of B cells in RA and reveals the origin of pathogenic …

17 天前 - … in Active Systemic Lupus Erythematosus) trials, the … of Care Compared with Placebo
Added to Standard of Care in … as the advancement of other therapeutic agents targeting …

18 天前 - … Thus, this review presents the research progress of pyroptosis in the development
of autoimmune skin disease, which may provide some enlightening for the clinical treatments…

21 天前 - … This Review will focus on the most recent advances in the immunology of SLE, those
that have … complexity 6,7 of the disease and new and future approaches to treat it (Fig. 1). …

27 天前 - … Lupus nephritis (LN) is the most common complication of systemic lupus
erythematosus and the leading cause of mortality. The complex pathogenesis and various clinical …

28 天前 - … Systemic Lupus Erythematosus (SLE) is a complex disease marked by extensive …
significant advancements in elucidating the pathogenesis of the disease, the management of …